- Moneycontrol /
- Market /
- Pharmaceuticals /
- HALF YEARLY RESULTS
BSE Live
Feb 20, 16:00Prev. Close
1407.85
Open Price
1410.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 20, 15:59Prev. Close
1402.90
Open Price
1412.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1454.70 (176)
| Half Yearly Results of Ipca Laboratories (in Rs. Cr.) | Sep '19 | Mar '19 | Sep '18 | Mar '18 | Sep '17 | |
| Net Sales/Income from operations | 2,223.57 | 1,781.40 | 1,851.75 | 1,641.96 | 1,577.25 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 2,223.57 | 1,781.40 | 1,851.75 | 1,641.96 | 1,577.25 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 709.41 | 560.32 | 537.70 | 450.87 | 472.33 | |
| Purchase of Traded Goods | 99.82 | 84.84 | 83.03 | 96.53 | 71.77 | |
| Increase/Decrease in Stocks | -37.00 | -76.48 | -29.66 | 2.44 | 18.54 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 425.19 | 353.07 | 399.17 | 350.91 | 361.87 | |
| Depreciation | 87.15 | 84.23 | 87.65 | 86.97 | 87.39 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 569.55 | 453.28 | 574.71 | 470.12 | 482.19 | |
| P/L Before Other | 369.45 | 322.14 | 199.15 | 184.12 | 83.16 | |
| Other Income | 33.76 | 27.21 | 27.38 | 22.36 | 17.18 | |
| P/L Before Int. | 403.21 | 349.35 | 226.53 | 206.48 | 100.34 | |
| Interest | 8.52 | 11.18 | 7.31 | 12.05 | 11.97 | |
| P/L Before Exceptional Items & Tax | 394.69 | 338.17 | 219.22 | 194.43 | 88.37 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 394.69 | 338.17 | 219.22 | 194.43 | 88.37 | |
| Tax | 66.62 | 68.52 | 33.96 | 37.54 | 12.15 | |
| P/L After Tax from Ordinary Activities | 328.07 | 269.65 | 185.26 | 156.89 | 76.22 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 328.07 | 269.65 | 185.26 | 156.89 | 76.22 | |
| Equity Share Capital | 25.27 | 25.27 | 25.27 | 25.24 | 25.24 | |
| Reserves Excluding Revaluation Reserves | 3,389.63 | -- | 2,847.82 | -- | 2,508.93 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 25.96 | -- | 14.66 | -- | 6.04 | |
| Diluted EPS | 25.96 | -- | 14.66 | -- | 6.04 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 25.96 | -- | 14.66 | -- | 6.04 | |
| Diluted EPS. | 25.96 | -- | 14.66 | -- | 6.04 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
